Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, University of Utah, School of Medicine, Salt Lake City, UT 84132, USA.
Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Utah, School of Medicine, Salt Lake City, UT 84132, USA.
Asian J Androl. 2021 Jan-Feb;23(1):11-15. doi: 10.4103/aja.aja_18_20.
This was a cohort study of in vitro fertilization (IVF) subjects at the University of Utah, Salt Lake City (UT, USA) utilizing partner sperm. Cycles where both the hamster egg penetration test (HEPT) and semen analysis were performed within 2 years prior to IVF cycles were stratified into four groups based on a normal or an abnormal HEPT and morphology. The mean conventional and intracytoplasmic sperm injection (ICSI) fertilization rates were calculated in each group. We performed a univariate analysis on the primary outcome comparing clinically interesting subjects. We performed a cost-effectiveness analysis of a policy of HEPT versus universal ICSI in couples with an abnormal morphology. Among patients with a normal HEPT, there was no difference in the mean conventional fertilization rates between those with a normal and an abnormal morphology. There was no difference in the mean conventional fertilization rates between subjects with a normal morphology without a hamster test and those with a normal HEPT without a morphology assessment. In 1000 simulated cycles with an abnormal morphology, a policy of HEPT was cost saving compared to universal ICSI, yet produced similar fertilization rates. The HEPT is similar to the World Health Organization edition 5 (WHO-5) morphology in predicting successful conventional fertilization while allowing decreased utilization of ICSI. A policy of HEPT for males with abnormal morphology saves cost in selecting couples for a fertilization method.
这是一项在犹他大学(美国盐湖城)进行的体外受精(IVF)对象的队列研究,使用伴侣精子。在 IVF 周期前 2 年内进行了仓鼠卵穿透试验(HEPT)和精液分析的周期根据 HEPT 和形态学的正常或异常分为四组。计算了每组中常规和胞浆内精子注射(ICSI)的平均受精率。我们对主要结局进行了单变量分析,比较了有临床意义的对象。我们对形态异常的夫妇中 HEPT 与普遍 ICSI 的政策进行了成本效益分析。在 HEPT 正常的患者中,形态正常和异常的患者常规受精率无差异。在没有仓鼠试验的形态正常的患者和没有形态评估的 HEPT 正常的患者之间,常规受精率无差异。在 1000 个形态异常的模拟周期中,与普遍 ICSI 相比,HEPT 策略具有成本效益,且产生相似的受精率。HEPT 在预测成功的常规受精方面与世界卫生组织第 5 版(WHO-5)形态学相似,同时减少了 ICSI 的使用。对于形态异常的男性,采用 HEPT 策略可节省选择受精方法的夫妇的成本。